Management of treatment‐naïve chronic hepatitis C genotype 1 patients: a cost‐effectiveness analysis of treatment options

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|2|175-183

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.2, 2015-02, pp. : 175-183

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Work productivity among treatment‐naïve patients with genotype 1 chronic hepatitis C infection receiving telaprevir combination treatment

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 1, 2015-01 ,pp. : 8-17

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of sofosbuvir for the treatment of chronic hepatitis C‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 11, 2015-11 ,pp. : 882-889

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of sofosbuvir for the treatment of chronic hepatitis C‐infected patients

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 1352-0504, Iss. 11, 2015-11 ,pp. : 882-889

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of sofosbuvir in the treatment of patients with hepatitis C

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 4, 2015-04 ,pp. : 376-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of all‐oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 544-563

John Wiley & Sons Inc

Access to resources Recommend Favorite